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Anionic alginate polymers were used to mimic human host cells for Candida






• Explore different biopolymer conditions, such as the alginate polymer modulus/ stiffness.
• Test encapsulation procedure at different environmental conditions within the alginate 
capsule (such as pH) and cell density, to observe biofilm formation or/and hyphal growth.
• By testing and varying these conditions, a better understanding of C. albicans 
pathogenic mechanisms can be understood, which can be used to reduce virulence 
and biofilm formation.
• Another possible future work involves multicellular compartments (MCCs) with C. 
albicans, to study cellular signaling, as is being done with E. coli cells in the Raghavan 
lab.
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Morpholology of C. albicans Tested at 35 oC and 37 oC in Alginate Capsules
Background and Motivation
Candida albicans is the most common fungal pathogen in humans and are the fourth leading 
cause of hospital-acquired bloodstream infections in the United States.1 While treatments exist, 
some species have shown increased resistance to antifungal agents, making rapid identification 
of disease-causing agents important for facilitating proper treatment. Candida albicans is a 
commensal opportunistic fungal pathogen. It is a polymorphic organism that exists in 
pseudohyphal and yeast forms in human hosts.2 C. albicans causes superficial and systemic 
infections, including oral thrush, vaginal yeast infections and systemic bloodstream infections. 
Systemic candidiasis can be deadly in immunocompromised patients such as transplant 
recipients and patients that have HIV, cancer, and diabetes mellitus.3 Due to the toxicity of 
antifungal therapies to human host cells, the resistance of C. albicans to antifungal therapies, 
and Candida’s ability to escape the white blood cells, newer approaches to better study C. 
albicans are needed. Encapsulation of yeast cells will allow observation of cell signaling, growth 
patterns, and, ultimately, enable development of better alternatives to prevent biofilm formation 
and C albicans hyphal growth, thereby limiting virulence. Anionic alginate polymers were used to 
mimic human host cells for Candida encapsulation observation. and C albicans strain SC5134 
was embedded in the capsules. 
• The polymorphic forms of C. albicans : Yeast and Hyphae were observed at 35 oC and 37 oC. The hyphal forms are more prevalent in the 
capsules incubated at 37 oC, and the cells incubated in capsules at 35 oC show predominantly yeast growth.
• . • A better understanding of C. 
albicans characteristics was 
observed by incubating the 
cells in YPD liquid and solid 
media at 35 oC and 37 oC,
followed by encapsulation in 
alginate polymer. The 
characteristics to be observed 
include cell adhesion, 
dimorphism, phenotypic 
switching, thigmotropism and 
biofilm formation. 
• C. Albicans strain SC5134 was centrifuged out from YPD media 
solution, washed with PBS buffer and stirred into already sterilized 
alginate solution. A syringe is then used to introduce the alginate + 
cells mixture into the receiving 0.1 M calcium chloride solution. The 
calcium chloride solution aids in crosslinking and capsule formation. 
This procedure is sufficient to produce macro-capsules. However, to 
produce microcapsules, a gas flow controller is often needed.
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Pathogenic Mechanism of C. albicans.2
Morpholology of C. albicans Tested at 35 oC and 37 oC in YPD Media
• The polymorphic forms of C. 
albicans : Yeast and 
pseudohyphae were 
observed at 35 oC and 37 oC 
in media. However, the 
hyphal forms are more 
prevalent in the 37 oC Cell 
culture as was expected.
35 oC                                                               37 oC 
35 oC                                                                        37 oC 
1. C. albicans characteristics such as cell adhesion , polymorphism, 
thigmotropism (directional growth) has been observed on both YPD solid 
media and within the alginate capsules.
2. Yeast form of C. albicans  has been observed to be predominant at 35 oC 
both on YPD solid media, and within the alginate capsules.
3. Hyphal and pseudohyphal forms of C. albicans  has been observed to be 
predominant at 37 oC both on YPD solid media, and within the alginate 
capsules.
Growth Curve of C. albicans
• The absorbance at 600 nm has been 
graphed against the colony forming unit per 
mL This graph will be used to vary the cell 
density of C. albicans within each capsule 
to test for difference in hyphae and biofilm 
formation, as well as cell signaling in future 
experiments.
